Presentation of HPV L2 Epitopes by using thioredoxin scaffold
The current invention provides a prophylactic HPV vaccine. Immunization against peptides from the HPV L2 protein gives a robust immune reaction that provides cross-protection against a variety of other high-risk HPV strains. Tha vaccine is based on a thioredoxin-L2 construct and can be produced in standard E. coli bacteria, which makes a cost-effective production feasible.
Further information: PDF
DKFZ (German Cancer Research Center, Deutsches Krebsforschungszentrum)
Phone: +49-6221-42 2955
Contact
Dr. Ruth Herzog
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Time to Leave Home? Revealed Insights into Brood Care of Cichlids
Shell-dwelling cichlids take intense care of their offspring, which they raise in abandoned snail shells. A team at the Max Planck Institute for Biological Intelligence used 3D-printed snail shells to…
Smart Fabrics: Innovative Comfortable Wearable Tech
Researchers have demonstrated new wearable technologies that both generate electricity from human movement and improve the comfort of the technology for the people wearing them. The work stems from an…
Going Steady—Study Reveals North Atlantic’s Gulf Stream Remains Robust
A study by the University of Bern and the Woods Hole Oceanographic Institution in the USA concludes that the ocean circulation in the North Atlantic, which includes the Gulf Stream,…